TMCnet News
Obalon Announces Upcoming Conference PresentationsSAN DIEGO, March 14, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced that Kelly Huang, Ph.D., President and Chief Operating Officer, and Bill Plovanic, Chief Financial Officer of Obalon, will participate in the following upcoming investor conference: 31st Annual ROTH Conference Tuesday, March 19, 2019, Presentation at 2:30pm PT Live audio webcast of the presentation can be accessed through the link above. Replays of the webcast will be available for 90 days following the presentation. About Obalon Therapeutics, Inc. For Obalon Therapeutics, Inc. Investor Contact: |